Boehringer Ingelheim Investigational Site

Montreal, Quebec H3Z, 2Z3

0 studies enrolling now · 8 studies all time

What they study most

Arthritis, Rheumatoid, Atrial Fibrillation, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, HIV Infections, Hypertension, Myocardial Infarction, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed
• To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways — Completed
• Tiotropium / Respimat One-Year Study — Completed
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed
• A Trial Evaluating the Efficacy and Safety of Tenecteplase Together With Unfractionated Heparin Prior to Early Percutaneous Coronary Intervention (PCI) as Compared to Standard Primary PCI in Patients With Acute Myocardial Infarction (ASSENT 4 PCI) — Stopped early